(They should) patronize Italian stores — at least they get something good. Because if it’s an Italian store, the Italians won’t buy garbage, and that store will go broke.” Tosi didn’t like to spend ...

Novo Nordisk announced its CagriSema GLP-1 weight loss drug underperformed Eli Lilly's tirzepatide in a trial. Separately, Lilly announced patients can use a single injector to hold a month's supply ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi ...

IMDb.com, Inc. n'assume aucune responsabilité quant au contenu ou à l'exactitude des articles de presse, des tweets ou des billets de blogue susmentionnés. Ce contenu est publié uniquement dans le but ...

Eli Manning's career speaks for itself, whether enshrined or not. It's that last part that sparks debate and outrage, even if the former New York Giants' star quarterback appears unbothered. Fans, ...

FanGraphs released their top 100 prospects for the 2026 season, and Washington Nationals 2025 first overall pick Eli Willits came in at No. 15. What got him drafted in that coveted spot was his ...

CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...

Though the Western genre is past its heyday, stories of cowfolk, lawmen, outlaws, and more have enjoyed a bit of a renaissance in recent years. Taylor Sheridan has been one of the biggest contributors ...

Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash. Eli Lilly on Monday said Orna, which is dedicated to engineering immune ...

Matthew Herper covers medical innovation — both its promise and its perils. Eli Lilly will pay up to $2.4 billion to acquire Orna Therapeutics, a biotechnology firm that is developing a technology to ...